FindTrial
Sign In

A Study Protocol for the Clinical Validation of an Ovarian Cancer Gene Methylation Detection Kit and Postoperative Recurrence Monitoring

A Study Protocol for the Clinical Validation of an Ovarian Cancer Gene Methylation Detection Kit and Postoperative Recurrence Monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123813
Enrollment
Unknown
Registered
2026-04-30
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

Gold Standard:Pathological diagnosis results ,Imaging results
Index test:Imaging results for ovarian cancer gene HOXA9, CDO1, BRCA1 methylation detection kit (PCR-fluorescent probe method)

Sponsors

Henan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Subjects with suspected ovarian cancer or other types of cancer; 2.Signed informed consent form obtained;

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Subjects who are HIV-positive or have other immunodeficiency diseases; 3.Subjects who have received a blood transfusion within the past month; 4.Subjects who have undergone a bone marrow transplant; 5.Any other reason deemed by the investigator;

Design outcomes

Primary

MeasureTime frame
Ovarian cancer;Accuracy;—

Countries

China

Contacts

Public ContactWei Bing

Henan Cancer Hospital

1140881981@qq.com+86 371 6558 7578

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026